Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Vineet Laboratories Ltd Fundamentals

Market Cap
₹ 48.57 Cr
P/E Ratio (TTM)
18.29
P/B Ratio
1.39
Debt to Equity
0.86
ROE
3.74
EPS (TTM)
2.88
Dividend Yield
0.00 %
Book Value
37.81

Click here to know more about Fundamentals

Vineet Laboratories Ltd Financials

Vineet Laboratories Ltd Financials

Vineet Laboratories Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Retail 59.07 % 58.68 % 58.66 % 58.47 %
Promoters 37.50 % 37.55 % 38.66 % 38.66 %
Others 3.43 % 3.53 % 2.68 % 2.87 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %
FII 0.00 % 0.24 % 0.00 % 0.00 %

Retail

59.07%

Promoters

37.50%

Others

3.43%

Mutual Funds

0.00%

FII

0.00%

Retail

58.68%

Promoters

37.55%

Others

3.53%

Mutual Funds

0.00%

FII

0.24%

Retail

58.66%

Promoters

38.66%

Others

2.68%

Mutual Funds

0.00%

FII

0.00%

Retail

58.47%

Promoters

38.66%

Others

2.87%

Mutual Funds

0.00%

FII

0.00%

Resistance and Support

₹55.17

PIVOT

resistance-arrow
Resistance
First Resistance₹57.283
Second Resistance₹59.067
Third Resistance₹61.183
support-arrow
Support
First Support₹53.383
Second Support₹51.267
Third Support₹49.483

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day3,32613,510100.00
Week13,5106,293306.19
1 Month13,5104,424306.19
6 Months5,785,2303,468,82689.14

About Vineet Laboratories Ltd

Vineet Laboratories Limited (Formerly known as Ortin Laboratories Limited) is a manufacturing company of intermediates useful for the manufacture of active pharmaceutical ingredients. The Company was incorporated on 10 November 2016 and operates in the business of API Intermediates, Bulk Drugs & fine chemicals. The production unit located at Malkapur Village, Yadadri- Bhuvanagiri District in Telangana State, India, is a multipurpose facility well equipped with stainless steel and glass-lined reactors with total volume of 230KL, of different volumes to suit any batch size. Special provisions are made to carry out reactions at very low temperature (up to -100°C). The Company is also specialized in manufacturing and handling pyrophoric chemicals like n-Butyl Lithium. The Company export the API intermediates, fine chemicals and custom synthesis molecules. The Company is interested in collaborating with exporters who want high quality products for export to other countries. In addition to the list of products enlisted in the website, the Company can manufacture as per customer requirements ,in case having any specific requirement. The Company constructed a warehouse with facilities for sampling both, dispensing booth, packing material room, rejected material room, intermediate room and a day storage for dispensed material 20 calibrated storage tanks from 10 KL to 40 KL available to store various solvents in dedicated tanks. All tanks are equipped with sprinklers and bund walls. The responsibility of Company's R&D department is to develop new and innovative products and explore cost effective technology for existing products. This Department is well equipped with all necessary infrastructures with research books, research journals and other online literature search platforms. The infrastructure is very versatile & specially designed to address the requirements of carrying out complex and hazardous chemical process safely and efficiently. The Company personnel are highly skilled at handling different kind of process chemistry. The Company is planning to start an ultra modern R & D facility for introducing new molecules of API intermediates, custom synthesis products, intermediates and chemicals etc. The multipurpose facility of the Company is well equipped with stainless steel and glass-lined reactors with total volume of 230 KL, of different volumes to suit any batch size. These reactors are provided with primary and secondary condensers, azeotropic boxes with facility to continue distillation under vacuum. Special provisions are made to carry out reactions at very low temperature up to -100°C and under inert atmosphere like nitrogen. Special equipment is in place to carryout reactions at high temperatures up to 250°C. Molecular distillation at hundred kilo batch size can be carried out. The Company is also specialized in manufacturing and handling pyrophoric chemicals like n-Butyl Lithium. The Company is associated with many domestic and overseas customers like Gilead Sciences, USA, Teva, Mylan Laboratories Ltd., Hyderabad, Orchid Chemicals And Pharmaceuticals Ltd., Hetero Drugs, Cipla Limited, Jubilant Organosys Ltd., etc. It strives constantly to keep customers happy with quality and schedule in delivery of products. The Quality Control Department is extensively equipped with modern analytical instrumentals like HPLCs (6No.s), GCs(4No.s), IR, Melting Range Apparatus, UV- vis Spectrophotometer, K.F. Titrator, etc. and staffed with trained analysts. It generates required analytical data for all quality related issues like routine analysis, investigations, validations, method development, compliance with guidelines like ICH, etc. The plant has been successfully audited by several multinational companies for compliance to the guidelines of quality system recommended by the ICHQ7 standard. The Company has been an ISO 9001: 2015 certified by the internationally recognized Quality Management Certification Body to enhance customer satisfaction by providing Quality Intermediates at optimum cost and maintain profitability through continual improvement of Quality Management Systems and cGMP. The Company is certified as an ISO 14001: 2015 by the internationally recognized Quality Management Certification Body, towards Environmental Management System. The Company is widely acknowledged for abilities in product development & process technology and is the preferred source for many MNCs for their outsourcing requirements.

Managing Director

2016

Founded

Gaddam Venkata Ramana

NSE Symbol

VINEETLAB

Vineet Laboratories Ltd Management

NameDesignation
Gaddam Venkata RamanaManaging Director
Bhupathiraju S RajuWhole Time Director & CFO
Kandula Murali MohanNon Executive Director
Dilip V AcharekarIndependent Director
K. Bhaskar ReddyIndependent Director
Nirosha RavikantiCompany Secretary
Yerukalapudi Hari PriyaAdditional Director
Rameshkumar BandariCompany Sec. & Compli. Officer

Vineet Laboratories Ltd News

Vineet Laboratories Ltd leads gainers in 'B' group
Shree Ganesh Remedies Ltd Partly Paidup, Crest Ventures Ltd, Everest Kanto Cylinder Ltd and Quick Heal Technologies Ltd are among the other gainers in the BSE's 'B' group today, 13 November 2023.
Vineet Laboratories reports standalone net profit of Rs 2.42 crore in the September 2023 quarter
Sales rise 9.77% to Rs 43.37 crore
Vineet Laboratories announces board meeting date
On 10 November 2023
Vineet Laboratories schedules AGM
On 28 September 2023
Vineet Laboratories reports standalone net loss of Rs 1.25 crore in the June 2023 quarter
Sales decline 23.15% to Rs 37.52 crore
Vineet Laboratories to conduct board meeting
On 12 August 2023
Vineet Laboratories standalone net profit rises 8.23% in the March 2023 quarter
Sales rise 2.90% to Rs 57.20 crore
Vineet Laboratories schedules board meeting
On 29 May 2023
Vineet Laboratories Ltd leads losers in 'B' group
DCM Ltd, Tarmat Ltd, NINtec Systems Ltd and Thomas Scott India Ltd are among the other losers in the BSE's 'B' group today, 06 March 2023.
Vineet Laboratories standalone net profit rises 2.21% in the December 2022 quarter
Sales rise 74.04% to Rs 66.76 crore

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
Sun Pharmaceuticals Industries Ltd₹ 367434.16 Cr
₹ 1,535.00
(0.24 %)
89.20
Cipla Ltd₹ 112958.59 Cr
₹ 1,405.05
(0.43 %)
30.42
Zydus Lifesciences Ltd₹ 105795.44 Cr
₹ 1,103.95
(5.00 %)
39.38
Divis Laboratories Ltd₹ 103818.12 Cr
₹ 3,924.30
(0.35 %)
76.14
Dr Reddys Laboratories Ltd₹ 96747.09 Cr
₹ 5,830.05
(0.53 %)
22.28

Vineet Laboratories Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Vineet Laboratories Ltd shares in BlinkX

Vineet Laboratories Ltd's P/E ratio is 18.29 times as of May 18, 2024 at 09:48 AM.

Vineet Laboratories Ltd's most recent financial reports indicate a price-to-book ratio of 1.39, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Vineet Laboratories Ltd's market is 49 Cr as on May 18, 2024 at 09:48 AM.

The current financial records of Vineet Laboratories Ltd show a 3.74% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

According to Vineet Laboratories Ltd's most recent financial filings, the company has a total asset value of Crores, which includes current and non-current assets such as inventory, cash, properties, and equipment.

As of the Mar 2024 quarter, the promoter shareholding in Vineet Laboratories Ltd stands at 37.50%. During the same period, Institutional Investors have shown a slight decrease in their holdings, dropping from 0.24% to 0.00%.